Virosomes of hepatitis B virus envelope L proteins containing doxorubicin: synergistic enhancement of human liver-specific antitumor growth activity by radiotherapy

References

• BertrandNWuJXuXKamalyNFarokhzadOCCancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biologyAdv Drug Deliv Rev20146622524270007
   PubMed Web of Science ®Google Scholar
• MaedaHWuJSawaTMatsumuraYHoriKTumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJ Control Release2000651–2274281
   Web of Science ®Google Scholar
• GorenDHorowitzATTzemachDNuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pumpClin Cancer Res2000651949195710815920
   PubMed Web of Science ®Google Scholar
• IinumaHMaruyamaKOkinagaKIntracellular targeting therapy of cisplatin-encapsulated transferrin-polyethylene glycol liposome on peritoneal dissemination of gastric cancerInt J Cancer200299113013711948504
   PubMed Web of Science ®Google Scholar
• LammersTKiesslingFHenninkWEStormGDrug targeting to tumors: principles, pitfalls and (pre-) clinical progressJ Control Release2012161217518721945285
   PubMed Web of Science ®Google Scholar
• KunjachanSPolaRGremseFPassive versus active tumor targeting using RGD- and NGR-modified polymeric nanomedicinesNano Lett201414297298124422585
   PubMed Web of Science ®Google Scholar
• TorchilinVPPassive and active drug targeting: drug delivery to tumors as an exampleHandb Exp Pharmacol201019735320217525
   PubMedGoogle Scholar
• HeermanKHGoldmanUSchwartzWLarge surface proteins of hepatitis B virus containing the pre-s sequenceJ Virol19845223964026492255
   PubMed Web of Science ®Google Scholar
• BrussVGanemDThe role of envelope proteins in hepatitis B virus assemblyProc Natl Acad Sci U S A1991883105910631992457
   PubMed Web of Science ®Google Scholar
• Le SeyecJChouteauPCannieIGuguen-GuillouzoCGriponPInfection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domainJ Virol1999733205220579971786
   PubMed Web of Science ®Google Scholar
• NeurathARKentSBStrickNParkerKIdentification and chemical synthesis of a host cell receptor binding site on hepatitis B virusCell19864634294363015414
   PubMed Web of Science ®Google Scholar
• KurodaSOtakaSMiyazakiTNakaoMFujisawaYHepatitis B virus envelope L protein particles: synthesis and assembly in Saccharomyces cerevisiae, purification, and characterizationJ Biol Chem19922673195319611370486
   PubMed Web of Science ®Google Scholar
• JungJIijimaMYoshimotoNEfficient and rapid purification of drug- and gene-carrying bio-nanocapsules, hepatitis B virus surface antigen L particles, from Saccharomyces cerevisiaeProtein Expr Purif201178214915521515381
   PubMed Web of Science ®Google Scholar
• YamadaTIwabukiHKannoTPhysicochemical and immunological characterization of hepatitis B virus envelope particles exclusively consisting of the entire L (pre-S1 + pre-S2 + S) proteinVaccine20011923–243154316311312011
   PubMed Web of Science ®Google Scholar
• YamadaMOedaAJungJHepatitis B virus envelope L protein-derived bio-nanocapsules: mechanisms of cellular attachment and entry into human hepatic cellsJ Control Release2012160232232922100387
   PubMed Web of Science ®Google Scholar
• YamadaTIwasakiYTadaHNanoparticles for the delivery of genes and drugs to human hepatocytesNat Biotechnol200321888589012833071
   PubMed Web of Science ®Google Scholar
• JungJMatsuzakiTTatematsuKBio-nanocapsule conjugated with liposomes for in vivo pinpoint delivery of various materialsJ Control Release2008126325526418207275
   PubMed Web of Science ®Google Scholar
• KasuyaTJungJKinoshitaRBio-nanocapsule-liposome conjugates for in vivo pinpoint drug and gene deliveryMethods Enzymol200946414716619903554
   PubMed Web of Science ®Google Scholar
• KanedaYVirosomes: evolution of the liposome as a targeted drug delivery systemAdv Drug Deliv Rev2000432–319720510967226
   PubMed Web of Science ®Google Scholar
• AllainCCPoonLSChanCSRichmondWFuPCEnzymatic determination of total serum cholesterolClin Chem19742044704754818200
   PubMed Web of Science ®Google Scholar
• LasicDDČehBStuartMCTransmembrane gradient driven phase transitions within vesicles: lessons for drug deliveryBiochim Biophys Acta1995123921451567488619
   PubMed Web of Science ®Google Scholar
• HaranGCohenRBarLKBarenholzYTransmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak basesBiochim Biophys Acta1993115122012158373796
   PubMed Web of Science ®Google Scholar
• OessSHildtENovel cell permeable motif derived from the PreS2-domain of hepatitis-B virus surface antigensGene Ther20007975075810822301
   PubMed Web of Science ®Google Scholar
• Rodríguez-CrespoINúñezEYélamosBFusogenic activity of hepadnavirus peptides corresponding to sequences downstream of the putative cleavage siteVirology1999261113314210441561
   PubMed Web of Science ®Google Scholar
• KobayashiMAsanoTUtsunomiyaMRecombinant hepatitis B virus surface antigen carrying the pre-S2 region derived from yeast: purification and characterizationJ Biotechnol198881121
   Web of Science ®Google Scholar
• BarenholzYDoxil® – the first FDA-approved nano-drug: lessons learnedJ Control Release2012160211713422484195
   PubMed Web of Science ®Google Scholar
• WangJByrneJDNapierMEDeSimoneJMMore effective nano-medicines through particle designSmall20117141919193121695781
   PubMed Web of Science ®Google Scholar
• XiaoKLiYLuoJThe effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticlesBiomaterials201132133435344621295849
   PubMed Web of Science ®Google Scholar
• WatashiKUrbanSLiWWakitaTNTCP and beyond: opening the door to unveil hepatitis B virus entryInt J Mol Sci20141522892290524557582
   PubMed Web of Science ®Google Scholar
• RazRKorenRBassDSafety and immunogenicity of a new mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens in adultsIsr Med Assoc J2001332833211411195
   PubMed Web of Science ®Google Scholar
• ShouvalDRoggendorfHRoggendorfMEnhanced immune response to hepatitis B vaccination through immunization with a pre-S1/pre-S2/S vaccineMed Microbiol Immunol2015204576825557605
   PubMed Web of Science ®Google Scholar
• LammersTHenninkWEStormGTumor-targeted nanomedicines: principles and practiceBr J Cancer200899339239718648371
   PubMed Web of Science ®Google Scholar
• LammersTSubrVPeschkePImage-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapyBr J Cancer200899690091019238631
   PubMed Web of Science ®Google Scholar